To the best of our knowledge, the relationship, correlation, and interaction of α‐syn and DJ‐1 in melanoma have not been explored so far, which motivated us to explore the possibility of conducting molecular docking using chemotherapeutic drugs to target our proteins of interest alone or as a complex. The gene discussed is PARK7; the disease is melanoma.